Page last updated: 2024-11-05

ici 204,219 and Constriction, Pathological

ici 204,219 has been researched along with Constriction, Pathological in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahlén, B1
Roquet, A1
Inman, MD1
Karlsson, O1
Naya, I1
Anstrén, G1
O'Byrne, PM1
Dahlén, SE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Controlled Trial of Marine Lipid Fraction PCSO-524™ on Airway Inflammation and Hyperpnea-Induced Bronchoconstriction in Asthma[NCT01504646]20 participants (Actual)Interventional2012-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for ici 204,219 and Constriction, Pathological

ArticleYear
Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction.
    The Journal of allergy and clinical immunology, 2002, Volume: 109, Issue:5

    Topics: Bronchial Diseases; Constriction, Pathologic; Cross-Over Studies; Double-Blind Method; Drug Therapy,

2002